BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han SH, Yi J, Kim JH, Lee S, Moon HW. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load. PLoS One 2019;14:e0212626. [PMID: 30785932 DOI: 10.1371/journal.pone.0212626] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Willis AD, Minot SS. Strategies to Facilitate Translational Advances from Microbiome Surveys. Trends Microbiol 2020;28:329-30. [PMID: 32298611 DOI: 10.1016/j.tim.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ke S, Pollock NR, Wang XW, Chen X, Daugherty K, Lin Q, Xu H, Garey KW, Gonzales-Luna AJ, Kelly CP, Liu YY. Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection. Gut Microbes 2021;13:1-18. [PMID: 34132169 DOI: 10.1080/19490976.2021.1935186] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Vakili B, Fateh A, Asadzadeh Aghdaei H, Sotoodehnejadnematalahi F, Siadat SD. Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection. Curr Microbiol 2020;77:1673-80. [DOI: 10.1007/s00284-020-01980-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jeon YD, Ann HW, Lee WJ, Kim JH, Seong H, Kim JH, Ahn JY, Jeong SJ, Ku NS, Yeom JS, Yong D, Lee K, Choi JY. Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea. Infect Chemother 2019;51:365-75. [PMID: 31898424 DOI: 10.3947/ic.2019.51.4.365] [Reference Citation Analysis]
5 Lee BH, Hsu WH, Chien HY, Hou CY, Hsu YT, Chen YZ, Wu SC. Applications of Lactobacillus acidophilus-Fermented Mango Protected Clostridioides difficile Infection and Developed as an Innovative Probiotic Jam. Foods 2021;10:1631. [PMID: 34359501 DOI: 10.3390/foods10071631] [Reference Citation Analysis]
6 Kiersnowska ZM, Lemiech-Mirowska E, Semczuk K, Michałkiewicz M, Sierocka A, Marczak M. Level of Knowledge of Medical Staff on the Basis of the Survey in Terms of Risk Management, Associated with Clostridioides difficile Infections. Int J Environ Res Public Health 2021;18:7060. [PMID: 34280996 DOI: 10.3390/ijerph18137060] [Reference Citation Analysis]
7 Ventero MP, Espinosa N, Jover R, Guillen Y, Merino E, Rodríguez JC. Evolution of intestinal microbiome in a process of faecal microbiota transfer (FMT) in a patient with Clostridioides difficile infection: NGS analysis with different software programs. Enferm Infecc Microbiol Clin (Engl Ed) 2021;39:184-7. [PMID: 32680797 DOI: 10.1016/j.eimc.2020.05.023] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Han SH, Yi J, Kim JH, Moon AH. Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic Clostridioides difficile Colonization and Infection. Microorganisms 2020;8:E882. [PMID: 32545219 DOI: 10.3390/microorganisms8060882] [Reference Citation Analysis]
9 Berry ASF, Kelly BJ, Barnhart D, Kelly DJ, Beiting DP, Baldassano RN, Redding LE. Gut microbiota features associated with Clostridioides difficile colonization in puppies. PLoS One 2019;14:e0215497. [PMID: 31469837 DOI: 10.1371/journal.pone.0215497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
10 Redding LE, Berry AS, Indugu N, Huang E, Beiting DP, Pitta D. Gut microbiota features associated with Clostridioides difficile colonization in dairy calves. PLoS One 2021;16:e0251999. [PMID: 34910727 DOI: 10.1371/journal.pone.0251999] [Reference Citation Analysis]
11 Sánchez-Pellicer P, Navarro-López V, González-Tamayo R, Llopis-Ruiz C, Núñez-Delegido E, Ruzafa-Costas B, Navarro-Moratalla L, Agüera-Santos J. Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile. Microorganisms 2021;9:1727. [PMID: 34442805 DOI: 10.3390/microorganisms9081727] [Reference Citation Analysis]
12 Herrera G, Paredes-Sabja D, Patarroyo MA, Ramírez JD, Muñoz M. Updating changes in human gut microbial communities associated with Clostridioides difficile infection. Gut Microbes 2021;13:1966277. [PMID: 34486488 DOI: 10.1080/19490976.2021.1966277] [Reference Citation Analysis]
13 Liu Y, Jiang Q, Liu Z, Shen S, Ai J, Zhu Y, Zhou L. Alteration of Gut Microbiota Relates to Metabolic Disorders in Primary Aldosteronism Patients. Front Endocrinol (Lausanne) 2021;12:667951. [PMID: 34484110 DOI: 10.3389/fendo.2021.667951] [Reference Citation Analysis]
14 Berkell M, Mysara M, Xavier BB, van Werkhoven CH, Monsieurs P, Lammens C, Ducher A, Vehreschild MJGT, Goossens H, de Gunzburg J, Bonten MJM, Malhotra-Kumar S; ANTICIPATE study group. Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat Commun 2021;12:2241. [PMID: 33854066 DOI: 10.1038/s41467-021-22302-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mizusawa M, Carroll KC. The future of Clostridioides difficile diagnostics. Curr Opin Infect Dis 2021;34:483-90. [PMID: 34524199 DOI: 10.1097/QCO.0000000000000754] [Reference Citation Analysis]
16 Chen Y, Lv T, Yan D, Zheng L, Zheng B, Wang J, Gu S, Li L. Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China. Front Cell Infect Microbiol 2022;12:825189. [DOI: 10.3389/fcimb.2022.825189] [Reference Citation Analysis]